Philip Morris International, Inc.

Equities

PM

US7181721090

Market Closed - Nyse Other stock markets 01:30:02 20/09/2024 am IST			5-day change	1st Jan Change
119.74 ^USD	-1.01%		-3.94%	+27.27%

18/09	Philip Morris Unit to Sell British Pharmaceuticals Business Vectura to Molex Asia	MT
17/09	Health Care Down as Novo Nordisk Slides on Drug-Price Fears - Health Care Roundup	DJ

Presentation Operator MessageOperator (Operator)Good day, and thank you for standing by. Welco...

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about Philip Morris International, Inc.

Philip Morris Unit to Sell British Pharmaceuticals Business Vectura to Molex Asia	18/09	MT
Health Care Down as Novo Nordisk Slides on Drug-Price Fears - Health Care Roundup	18/09	DJ
Philip Morris International Affiliate Vectura Fertin Pharma to Sell Vectura Group to Molex	17/09	MT
Philip Morris to sell Vectura for $198 million after health shift criticism	17/09	RE
Philip Morris International Increases Dividend to $1.35 per Share From $1.30; Payable on Oct. 10 to Shareholders of Record on Sept. 26	12/09	MT
Philip Morris Raises Quarterly Dividend by 3.8% to $1.35	12/09	DJ
UBS Raises Price Target on Philip Morris International to $105 From $95, Maintains Sell Rating	09/09	MT
Philip Morris: the number of counterfeit cigarettes in Europe is a cause for concern	09/09	CF
Barclays Raises Price Target on Philip Morris International to $145 From $130	09/09	MT
Stifel Nicolaus Adjusts Philip Morris International Price Target to $138 From $120, Maintains Buy Rating	04/09	MT
Philip Morris International Inc. Presents at Barclays 17th Annual Global Consumer Staples Conference, Sep-03-2024 12:45 PM	03/09
Philip Morris' Swedish Match to Invest $232 Million in US Production Facility Expansion	28/08	MT
Philip Morris to invest $232 million to expand ZYN production at Kentucky plant	27/08	RE
Philip Morris International Invests $232 Million to Expand Kentucky Facility	27/08	MT
Market on edge, anticipating Powell's play	23/08
Analyst recommendations: Abbvie, Cbre group, Snowflake, Intuit, Lockheed Martin...	23/08
Barclays Adjusts Price Target on Philip Morris International to $130 From $110	14/08	MT
Philip Morris International Insider Sold Shares Worth $1,038,150, According to a Recent SEC Filing	13/08	MT
Developers of vapes for migraine, asthma will need to win over sceptics	09/08	RE
Jefferies Adjusts Philip Morris International Price Target to $129 From $123	05/08	MT
KT&G Signs Deal with Philip Morris International on Regulatory Submissions with US FDA	01/08	MT
Illicit nicotine pouches on the rise in US, Altria CEO says	31/07	RE
Philip Morris International, KT&G to Collaborate on US Regulatory Submissions	30/07	MT
Philip Morris International Insider Sold Shares Worth $2,260,200, According to a Recent SEC Filing	29/07	MT
JPMorgan Adjusts Price Target on Philip Morris International to $125 From $110	25/07	MT